Can you provide the last earnings date for CARISMA THERAPEUTICS INC?
CARISMA THERAPEUTICS INC (CARM) last reported earnings on 8/7/2025.
CARISMA THERAPEUTICS INC (CARM) Earnings History & Surprises
NASDAQ:CARM • US14216R1014
Current stock price
0.1539 USD
-0.12 (-43.81%)
At close:
0.1181 USD
-0.04 (-23.26%)
After Hours:
CARM Earnings overview
Past quarterly earnings results for CARISMA THERAPEUTICS INC (CARM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Nov 5, 2025
- Period
- Q3 / 2025
- EPS Estimate
- -$0.12
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Aug 7, 2025
- Period
- Q2 / 2025
- EPS Reported
- -$0.23
- EPS Surprise
- -150.54%
- Revenue Surprise
- -100.00%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.23 | -0.09 | -150.54% | 14.81% | 3.825M | -100.00% | -100.00% | |
| Q1 2025 | -0.22 | -0.12 | -79.74% | 52.17% | 3.729M | 3.825M | -2.51% | 9.77% |
| Q4 2024 | -0.42 | -0.17 | -153.39% | 19.23% | 3.653M | 5.528M | -33.92% | -14.83% |
| Q3 2024 | -0.31 | -0.27 | -16.89% | 41.51% | 3.385M | 5.576M | -39.29% | -11.55% |
| Q2 2024 | -0.27 | -0.30 | 11.02% | 44.90% | 9.197M | 4.004M | 129.70% | 158.34% |
| Q1 2024 | -0.46 | -0.44 | -4.27% | 76.17% | 3.397M | 4.488M | -24.31% | 4.75% |
| Q4 2023 | -0.52 | -0.56 | 7.73% | 35.00% | 4.289M | 2.958M | 45.00% | - |
| Q3 2023 | -0.53 | -0.58 | 8.80% | -126.50% | 3.827M | 1.224M | 212.66% | -90.43% |
| Q2 2023 | -0.49 | -0.61 | 19.49% | 84.69% | 3.56M | 1.088M | 227.21% | - |
| Q1 2023 | -1.93 | -0.91 | -112.60% | - | 3.243M | 3.806M | -14.79% | - |
| Q4 2022 | -0.80 | -2.24 | 64.35% | -200.00% | - | -100.00% | ||
| Q3 2022 | 2.00 | -1.63 | 222.55% | 455.56% | 40M | - | - | |
| Q2 2022 | -3.20 | -2.65 | -20.66% | -2,033.33% | - | -100.00% | ||
| Q1 2022 | 0.00 | -2.04 | 100.00% | 100.00% | - | -100.00% | ||
| Q4 2021 | 0.80 | -1.50 | 153.48% | 827.27% | 20M | - | - | |
| Q3 2021 | 0.36 | -0.07 | 604.20% | 289.47% | 543.997K | -100.00% | -100.00% | |
| Q2 2021 | -0.15 | -0.06 | -132.21% | 37.50% | 2.23M | - | - | |
| Q1 2021 | -0.35 | -0.08 | -347.55% | -212.90% | 4.31M | - | - | |
| Q4 2020 | -0.11 | -0.11 | -1.10% | - | - | - | ||
| Q3 2020 | -0.19 | -0.08 | -132.84% | - | 11.24M | - | - | |
| Q2 2020 | -0.24 | -0.10 | -152.11% | - | - | - | ||
| Q1 2020 | 0.31 | -0.09 | 450.67% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
0
Average EPS beat (4)
-100.14%
Max EPS beat (4)
-16.89%
Min EPS beat (4)
-153.39%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-43.93%
Max Revenue beat (4)
-2.51%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, CARM has not beaten EPS estimates in any release
CARM has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, CARM reported -100.1% below the EPS estimates on average.
In the last 4 quarters, CARM reported -43.9% below the revenue estimates on average.
Related analysis
CARISMA THERAPEUTICS INC / CARM Earnings FAQ
Did CARISMA THERAPEUTICS INC (CARM) beat earnings estimates last quarter?
CARISMA THERAPEUTICS INC (CARM) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often CARISMA THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, CARISMA THERAPEUTICS INC (CARM) has beaten EPS estimates in 0 out of 4 releases.